Bicara Therapeutics Inc. (BCAX) SEC filings
BCAX SEC filings moved a median of +1.31% by the close. BCAX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the BCAX overview →
35 measured BCAX SEC filing events.
Where these BCAX SEC filings landedvs 34 measured BCAX SEC filing reactions
| Middle 50% of BCAX SEC filing reactions | -0.29% to +2.59% |
|---|---|
| Median reaction (to close) | +1.31% |
| Measured reactions | 34 |
Point-in-time · zero look-ahead
Half of the 34 BCAX SEC filing events with a measured close landed between -0.29% and +2.59%; 65% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Bicara Therapeutics Inc. For: Aug 21 | SEC filing · Form 8-K | -0.59% | +0.81% | |
| Form 10-Q Bicara Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.06% | +2.63% | |
| Form 8-K Bicara Therapeutics Inc. For: Aug 11 | SEC filing · Form 8-K | +11.54% | +4.21% | |
| Form S-8 Bicara Therapeutics Inc. | SEC filing · Form S-8 | +1.06% | +2.63% | |
| Form 8-K Bicara Therapeutics Inc. For: Jul 23 | SEC filing · Form 8-K | -0.36% | -2.68% | |
| Form 8-K Bicara Therapeutics Inc. For: Jun 09 | SEC filing · Form 8-K | -1.08% | +4.42% | |
| Form 8-K Bicara Therapeutics Inc. For: May 21 | SEC filing · Form 8-K | -0.92% | +4.03% | |
| Form 10-Q Bicara Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.02% | -2.40% | |
| Form 8-K Bicara Therapeutics Inc. For: May 11 | SEC filing · Form 8-K | -1.33% | +1.91% | |
| Form ARS Bicara Therapeutics Inc. For: Apr 21 | SEC filing · Form ARS | +1.11% | -0.29% | |
| Form DEF 14A Bicara Therapeutics Inc. For: Apr 21 | SEC filing · Form DEF | +1.11% | -0.29% | |
| Form DEFA14A Bicara Therapeutics Inc. | SEC filing · Form DEFA14A | +1.11% | -0.29% | |
| Form S-8 Bicara Therapeutics Inc. | SEC filing · Form S-8 | -0.08% | +2.47% | |
| Form 10-K Bicara Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -0.08% | +2.47% | |
| Form 8-K Bicara Therapeutics Inc. For: Mar 30 | SEC filing · Form 8-K | -3.55% | +0.90% | |
| Form 8-K Bicara Therapeutics Inc. For: Feb 24 | SEC filing · Form 8-K | +0.98% | -0.12% | |
| Form 8-K Bicara Therapeutics Inc. For: Feb 19 | SEC filing · Form 8-K | +1.69% | +0.58% | |
| Form 8-K Bicara Therapeutics Inc. For: Jan 12 | SEC filing · Form 8-K | -2.45% | -2.90% | |
| Form 8-K Bicara Therapeutics Inc. For: Dec 06 | SEC filing · Form 8-K | +0.19% | +2.38% | |
| Form EFFECT Bicara Therapeutics Inc. | SEC filing · Form EFFECT | -0.16% | -2.16% | |
| Form 10-Q Bicara Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.40% | +6.74% | |
| Form 8-K Bicara Therapeutics Inc. For: Nov 10 | SEC filing · Form 8-K | +3.38% | -5.75% | |
| Form S-3 Bicara Therapeutics Inc. | SEC filing · Form S-3 | +1.11% | +5.81% | |
| Form 10-Q Bicara Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.52% | +6.58% | |
| Form 8-K Bicara Therapeutics Inc. For: Aug 12 | SEC filing · Form 8-K | +0.45% | — | |
| Form 8-K Bicara Therapeutics Inc. For: Jun 09 | SEC filing · Form 8-K | +0.00% | -3.13% | |
| Form 8-K Bicara Therapeutics Inc. For: Jun 02 | SEC filing · Form 8-K | -0.64% | -1.88% | |
| Form 10-Q Bicara Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.83% | +3.79% | |
| Form 8-K Bicara Therapeutics Inc. For: May 13 | SEC filing · Form 8-K | +0.00% | -8.10% | |
| Form ARS Bicara Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | -0.82% | +1.72% | |
| Form DEF 14A Bicara Therapeutics Inc. For: Jun 09 | SEC filing · Form DEF | -0.82% | +1.72% | |
| Form DEFA14A Bicara Therapeutics Inc. | SEC filing · Form DEFA14A | -0.82% | +1.72% | |
| Form S-8 Bicara Therapeutics Inc. | SEC filing · Form S-8 | +6.05% | +0.07% | |
| Form 10-K Bicara Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +6.05% | +0.07% | |
| Form 8-K Bicara Therapeutics Inc. For: Mar 27 | SEC filing · Form 8-K | +0.57% | +2.29% |
Keep exploring
More BCAX: earnings → · analyst actions → · BCAX overview →